The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,960.00
Bid: 1,969.00
Ask: 1,971.00
Change: 35.00 (1.82%)
Spread: 2.00 (0.102%)
Open: 1,937.00
High: 1,977.00
Low: 1,931.00
Prev. Close: 1,925.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FTSE 100 movers: BP leads market fallers on losses

Tue, 02nd Feb 2016 14:13

(ShareCast News) - The FTSE 100 was back below 6,000 on Tuesday, dropping 151.22 points (2.5%) to 5,908.88 by mid-afternoon.BP took the biggest hit after $2.6bn of write-downs and restructuring charges sent it crashing into losses for the fourth quarter and full year.A $3.31bn loss was reported for the fourth quarter, with underlying profits crashing 91% to $196m, well shy of forecasts, sending the oil major to a $6.48bn full year loss, with annual underlying profits plunging by just over half to $5.9bn. Underlying operating cash flow for the fourth quarter of 2015 remained solid at $5.9bn, but while the total for the year stood at $20.3bn, this was down by more than a third on 2014.Although the slump in the oil price sent the upstream business into a loss in the final quarter, the downstream arm partially offset this with a strong set of counter-cyclical results of flat profits compared to the prior year. Cash costs were down by $3.4bn during the year, and are due to be $7m lower in 2017, with $3-5bn of divestments planned for 2016 taking further pressure off the balance sheet.BHP Billiton and Rio Tinto also suffered after Standard & Poors downgraded BHP's credit after the close on Monday and said a further cut is possible, while Rio Tinto was placed under 'creditwatch negative'.The credit agency said after recently cutting its price assumptions for commodities such as iron ore, oil, and copper due to the mismatch between demand and supply, BHP could suffer from its ratio of funds from operations-to-debt falling to 30%-40% over the next two years. As a result it has cut the company's credit rating to 'A' from 'A+', with the creditwatch category reflecting the possibility that the rating may well be cut by a further notch after the group's earnings release in late February, largely depending on the announced dividend policy and capital expenditure guidance. Cuts to forecast commodities prices for iron ore, aluminum, and copper affect Rio Tinto, so S&P feels it could also reduce its the 'A-/A-2' corporate bond rating by one notch after group's earnings release in early February, so has slapped it with a 'creditwatch negative' tag as well.Prudential fell on headlines that China is unleashing new steps to control financial risks and outflows. Bloomberg reported that the currency regulator is imposing restrictions on buying insurance products overseas, specifically a $5,000 cap on insurance products paid for using UnionPay debit and credit cards."This is just one method of payment Prudential uses," said one analyst. "When it rains it pours with negative news around Prudential. This story in itself doesn't seem a big deal but will add further worries about contagion risk in the Chinese financial system."Of the few big risers, Hikma Pharmaceutical was up after Bank of America/Merrill Lynch upgraded the company from 'neutral' to 'buy'. It said the purchase of Roxane Laboratories should bring substantial benefits to the company.Sainsbury was also up after it came to an agreement over the terms of a deal to buy Home Retail Group valued at £1.3bn.Home Retail shareholders will receive 55p in cash and 0.321 Sainsbury's shares for each of their Home shares. They will also receive a payout of 25p per share to reflect the £200m capital return from the sale of Homebase and 2.8p in lieu of a final dividend in respect of the financial year ending 27 February. Sainsbury's said the combination of the two groups was "an attractive proposition for the customers and shareholders of both companies, establishing a platform for long-term value creation". FTSE 100 - RisersHikma Pharmaceuticals (HIK) 2,089.00p 2.96%Sainsbury (J) (SBRY) 250.20p 2.29%Associated British Foods (ABF) 3,193.00p 1.37%Worldpay Group (WI) (WPG) 310.80p 0.26%BT Group (BT.A) 495.20p 0.20%Admiral Group (ADM) 1,771.00p 0.17%FTSE 100 - FallersBP (BP.) 332.65p -9.35%Anglo American (AAL) 248.55p -9.30%Prudential (PRU) 1,214.50p -8.44%BHP Billiton (BLT) 627.90p -7.40%Standard Chartered (STAN) 429.25p -6.68%Glencore (GLEN) 82.31p -6.46%Rio Tinto (RIO) 1,599.00p -5.72%Carnival (CCL) 3,321.00p -5.52%Rolls-Royce Holdings (RR.) 525.50p -5.32%Royal Dutch Shell 'B' (RDSB) 1,422.50p -5.17% (Sharecast News)
More News
3 Jan 2023 09:25

Hikma launches version of Xyrem medicine in US for treating narcolepsy

(Alliance News) - Hikma Pharmaceuticals PLC on Tuesday said it launched an authorised generic version of the Xyrem sodium oxybate prescription medicine in the US for treating narcolepsy.

Read more
3 Jan 2023 09:24

LONDON BROKER RATINGS: Citigroup cuts Wizz Air; Redburn likes CRH

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning, Monday and late Friday:

Read more
3 Jan 2023 09:03

LONDON MARKET OPEN: Stocks jump in first session of 2023

(Alliance News) - Stock prices in London made a strong start to the new year on Tuesday, despite weak Chinese data and the UK suffering a fresh wave of rail strikes.

Read more
3 Jan 2023 07:58

LONDON BRIEFING: Stocks called higher; China factory sector shrinks

(Alliance News) - Stocks in London are expected to start a new year on the front foot on Tuesday, after a mixed session in Asia amid weak Chinese economic data.

Read more
3 Jan 2023 07:46

Hikma launches generic narcolepsy solution in US

(Sharecast News) - Hikma Pharmaceuticals has launched an authorised generic version of Jazz Pharmaceuticals' 'Xyrem 1', or sodium oxybate oral solution, it announced on Tuesday.

Read more
8 Dec 2022 09:48

LONDON BROKER RATINGS: JPMorgan cuts Travis Perkins; BofA likes IAG

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
6 Dec 2022 10:48

RBC Capital Markets starts Hikma at 'outperform'

(Sharecast News) - RBC Capital Markets initiated coverage of Hikma Pharmaceuticals on Tuesday at 'outperform' with a 1,750p price target.

Read more
6 Dec 2022 10:26

LONDON BROKER RATINGS: JPMorgan cuts Lloyds but raises Barclays

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
15 Nov 2022 12:10

Credit Suisse initiates coverage of Hikma at 'outperform'

(Sharecast News) - Credit Suisse has initiated coverage of Hikma Pharmaceuticals with an 'outperform' rating.

Read more
15 Nov 2022 09:58

LONDON BROKER RATINGS: Jefferies cuts Aston Martin to 'underperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
14 Nov 2022 09:25

LONDON BROKER RATINGS: Credit Suisse cuts Ferrexpo to 'neutral'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
8 Nov 2022 09:39

LONDON BROKER RATINGS: Peel cuts Persimmon; Liberum raises Hammerson

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
3 Nov 2022 11:17

Hikma Pharmaceuticals reiterates 2022 guidance as costs widen

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reiterated annual guidance for all three of its businesses, continuing to expect them to underperform against 2021 due to rising costs.

Read more
3 Nov 2022 11:08

With tighter purse strings, is parity less probable for the pound?

STOXX 600 down 1.1%

*

Read more
3 Nov 2022 09:28

Banks, insurance dodge carnage as real estate stocks sink

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at .

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.